Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.

Authors :: Carnicelli AP
De Caterina R
Halperin JL
Renda G
Ruff CT
Trevisan M
Nordio F
Mercuri MF
Antman E
Giugliano RP
Source :: Circulation [Circulation] 2017 Mar 28; Vol. 135 (13), pp. 1273-1275. Date of Electronic Publication: 2017 Feb 16.
Publication Year :: 2017

Subjects :: Anticoagulants adverse effects
Atrial Fibrillation blood
Atrial Fibrillation complications
Atrial Fibrillation diagnosis
Blood Coagulation drug effects
Factor Xa Inhibitors adverse effects
Heart Valve Prosthesis Implantation adverse effects
Hemorrhage chemically induced
Humans
Pyridines adverse effects
Risk Factors
Stroke blood
Stroke diagnosis
Stroke etiology
Thiazoles adverse effects
Thromboembolism blood
Thromboembolism diagnosis
Thromboembolism etiology
Treatment Outcome
Warfarin adverse effects
Anticoagulants administration & dosage
Atrial Fibrillation drug therapy
Bioprosthesis adverse effects
Factor Xa Inhibitors administration & dosage
Heart Valve Prosthesis adverse effects
Heart Valve Prosthesis Implantation instrumentation
Pyridines administration & dosage
Stroke prevention & control
Thiazoles administration & dosage
Thromboembolism prevention & control
Warfarin administration & dosage

Full Text Access

Tools